Two obesity medicine societies and an advocacy group have teamed up to produce US-specific evidence-based guidance on obesity ...

A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as ...

Researchers have identified a neural biomarker of compulsive food cravings, and showed that it is suppressed by the ...

A groundbreaking study has revealed how obesity drug Mounjaro affects brain signals linked to cravings. Researchers observed ...

Tirzepatide therapy was associated with neutral effects on heart failure outcomes among patients with type 2 diabetes and/or obesity.

COVID-19 symptoms that don’t go away affect hundreds of millions worldwide. Scripps Research is recruiting people with long ...

Real-world data come from over 4000 women with polycystic ovary syndrome and overweight/obesity enrolled in a digital ...

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...

Among people with obesity or overweight, tirzepatide users lost 20.2% of body weight compared with a 13.7% loss with semaglutide over 72 weeks. Participants on tirzepatide also lost 5.4 cm more in ...

Tirzepatide was linked to improved weight loss outcomes in patients with PCOS, especially those who used a digital weight ...

The topic of obesity and metabolic disease will take centre stage at the upcoming 53rd Annual Conference of the Research ...

A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as ...